DRAFT — this day has not been cleared by the rotation director. Numbers and wording may change. Do not rely on it clinically.

PACU · Day 1 of 20

Residual block is common, invisible, and dangerous

Residual neuromuscular blockade below a train-of-four ratio of 0.9 is common, is not detectable by clinical examination or qualitative nerve stimulation, and is strongly associated with critical respiratory events in the PACU.

Consensus only · rests on registry data mechanism established clinical claim associational

Why it matters

The patient who arrives in the PACU breathing, obeying commands and holding their head up can still have a train-of-four ratio far below the threshold at which the pharyngeal muscles protect the airway. In RECITE-US, patients were judged suitable for extubation by routine clinical judgement and qualitative peripheral nerve stimulation, and 64.7% of them (165 of 255) had a TOF ratio below 0.9 at extubation, with 31.0% of those below 0.6 saager-2019. The examination that was supposed to catch residual block passed two-thirds of the patients who had it.

The consequence of getting this wrong arrives in the first minutes of the PACU stay, as hypoxaemia or airway obstruction in a patient nobody thought was at risk.

Mechanism

Non-depolarising blockers occupy nicotinic receptors at the neuromuscular junction. Recovery is a gradient: the diaphragm and the large muscles that generate a head lift or a hand grip recover before the small muscles of the pharynx and the upper oesophagus that keep the airway open and protect it from aspiration. A patient can therefore breathe adequately and pass every bedside test while the muscles that matter in the PACU are still partly blocked. Qualitative nerve stimulation, watching or feeling for fade, cannot resolve the difference between a TOF ratio of 0.5 and 0.9; only a quantitative monitor that measures the ratio can. That gap between what the bedside can see and what the junction is doing is the whole mechanism of the day.

Evidence

Murphy 2008 screened 7459 general anaesthetics over one year; 61 patients developed a predefined critical respiratory event in the first 15 min of PACU stay, and 42 were matched to controls murphy-2008. Mean TOF ratio was 0.62 (SD 0.20) in cases and 0.98 (SD 0.07) in controls, a difference of 0.36 (95% CI 0.30 to 0.43, P less than 0.0001); 73.8% of cases had a TOF ratio below 0.70 and no control did murphy-2008. The commonest events were severe hypoxaemia in 22 of 42 (52.4%) and upper airway obstruction in 15 of 42 (35.7%) murphy-2008.

RECITE-US supplies the prevalence: in a blinded multicentre cohort across 10 US community and academic hospitals, 64.7% of patients had residual block at extubation despite having been judged suitable for extubation by clinical judgement and qualitative stimulation saager-2019. The Canadian RECITE study is the companion incidence estimate; its primary record has not been reached, so no figure from it appears here fortier-2015.

The 2023 ASA practice guideline states a TOF ratio of 0.9 or more as the recovery threshold, recommends quantitative monitoring over qualitative or clinical assessment, recommends sugammadex for deep, moderate and shallow rocuronium- or vecuronium-induced block, describes neostigmine as a reasonable alternative only from minimal block (TOF ratio 0.4 to less than 0.9), and states that patients with a documented quantitative TOF ratio of 0.9 or more do not require pharmacological antagonism thilen-2023.

POPULAR, a prospective cohort of 22,803 patients from 211 hospitals in 28 European countries, found that use of neuromuscular blocking agents was associated with postoperative pulmonary complications, adjusted OR 1.86 (95% CI 1.53 to 2.26), and reported that neither reversal agents nor neuromuscular monitoring reduced that risk in the cohort kirmeier-2019. Its primary endpoint was a complication occurring or persisting after PACU discharge, so block treated in the PACU is largely excluded from it kirmeier-2019.

An exploratory reanalysis of POPULAR compared a 0.95 with a 0.9 extubation threshold and carries the contested position that 0.9 may be too permissive; that position has been disputed in print blobner-2020.

What this does not show

No randomised trial shows that residual block below 0.9 causes PACU respiratory morbidity, and there could not easily be one murphy-2008. Murphy 2008 is a matched case-control study nested in a single-centre cohort; RECITE-US and POPULAR are observational cohorts; the ASA document is a guideline murphy-2008 saager-2019 kirmeier-2019 thilen-2023. The association is strong and consistent. Whether monitoring and reversal prevent the harm is not established here, and POPULAR points the other way for the complications it measured kirmeier-2019. That is why the claim says common, invisible and associated, and not most preventable.

The threshold itself is a convention under challenge. The reanalysis arguing for 0.95 is exploratory and contested, and this page does not adopt it blobner-2020.

Items on the director’s content list for this day that the held sources do not carry are placeholders: [NUMBER NEEDED: sustained head lift and other clinical signs, their sensitivity for TOF below 0.9] [NUMBER NEEDED: neostigmine ceiling dose and the paradoxical weakness described when it is given at deep block] [NUMBER NEEDED: sugammadex dosing by depth of block, recurarisation, hormonal contraceptive interaction, bradycardia and anaphylaxis]. [TODO_VERIFY: edrophonium availability in the United States; the retrieval notes record every brand as discontinued, to be confirmed against the FDA discontinued drug product list before any reversal content names it.]

At the bedside

Measure, do not judge. A quantitative TOF ratio is the only bedside finding on this page that distinguishes a recovered junction from a blocked one, and the guideline recommends it over clinical assessment thilen-2023. A head lift or a hand grip tells you about large muscles that recover first.

If the ratio is documented at 0.9 or more, no antagonism is needed; if it is below 0.9, the choice of agent depends on the measured depth, with neostigmine reasonable only from minimal block thilen-2023. [PRACTICE VARIES: the institutional preference between sugammadex and neostigmine, and the availability of quantitative monitors in the PACU, differ between hospitals.]

Treat hypoxaemia or airway obstruction in the first minutes of PACU stay as residual block until a monitor says otherwise, because those were the two commonest events in the matched cohort and the cases were, on average, still deeply blocked murphy-2008.

Sources

Every number above carries its ledger key. Each key below resolves to the source record.

[[murphy-2008]] cohort 2008 n: 7459 screened; 61 CREs; 42 matched case-control pairs analysed paywalled

Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008 Jul;107(1):130-137.

7459 general anaesthetics over 1 yr; 61 developed a predefined critical respiratory event in the first 15 min of PACU stay; 42 matched to controls; mean TOF ratio 0.62 (SD 0.20) in cases vs 0.98 (SD 0.07) in controls, difference -0.36 (95% CI -0.43 to -0.30, P<0.0001); 73.8% of cases had TOF <0.70 vs 0 controls; commonest CREs severe hypoxaemia 22/42 (52.4%) and upper airway obstruction 15/42 (35.7%)

[[saager-2019]] cohort 2019 n: 255 paywalled

Saager L, Maiese EM, Bash LD, Meyer TA, Minkowitz H, Groudine S, Philip BK, Tanaka P, Gan TJ, Rodriguez-Blanco Y, Soto R, Heisel O. Incidence, risk factors, and consequences of residual neuromuscular block in the United States: the prospective, observational, multicenter RECITE-US study. J Clin Anesth. 2019 Aug;55:33-41.

Blinded multicentre cohort in operating and recovery rooms of 10 US community and academic hospitals; 64.7% (165/255) had residual block (TOF ratio <0.9) at extubation; 31.0% of those had TOF ratio <0.6; patients were judged suitable for extubation by routine clinical judgement and qualitative peripheral nerve stimulation

[[thilen-2023]] guideline 2023 n: NA open

Thilen SR, Weigel WA, Todd MM, Dutton RP, Lien CA, Grant SA, Szokol JW, Eriksson LI, Yaster M, Grant MD, Agarkar M, Marbella AM, Blanck JF, Domino KB. 2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade. Anesthesiology. 2023 Jan 1;138(1):13-41.

TOF ratio >=0.9 is the stated recovery threshold; quantitative monitoring recommended over qualitative/clinical assessment; sugammadex recommended for deep, moderate and shallow rocuronium- or vecuronium-induced block; neostigmine described as a reasonable alternative only from minimal block (TOF ratio 0.4 to <0.9); patients with documented quantitative TOF ratio >=0.9 do not require pharmacologic antagonism

[[kirmeier-2019]] cohort 2019 n: 22803 paywalled

Kirmeier E, Eriksson LI, Lewald H, Jonsson Fagerlund M, Hoeft A, Hollmann M, Meistelman C, Hunter JM, Ulm K, Blobner M; POPULAR Contributors. Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study. Lancet Respir Med. 2019 Feb;7(2):129-140.

22,803 patients from 211 hospitals in 28 European countries; use of neuromuscular blocking agents associated with postoperative pulmonary complications, adjusted OR 1.86 (95% CI 1.53-2.26); the authors report that neither use of reversal agents nor use of neuromuscular monitoring reduced that risk in this cohort; primary endpoint was any POPC occurring or persisting after PACU discharge, so PACU-treated residual block is largely excluded from it

[[blobner-2020]] cohort 2020 n: UNVERIFIED paywalled

Blobner M, Hunter JM, Meistelman C, Hoeft A, Hollmann MW, Kirmeier E, Lewald H, Ulm K. Use of a train-of-four ratio of 0.95 versus 0.9 for tracheal extubation: an exploratory analysis of POPULAR data. Br J Anaesth. 2020 Jan;124(1):63-72.

Exploratory reanalysis of POPULAR data comparing a 0.95 versus 0.9 TOF-ratio extubation threshold; carries the contested position that the conventional 0.9 threshold may be too permissive. Contested by Fuchs-Buder and Brull, Br J Anaesth 2020;124:12-14 (PMID 31685216)

[[fortier-2015]] cohort 2015 n: UNVERIFIED paywalled

Fortier LP, McKeen D, Turner K, et al. The RECITE Study: a Canadian prospective, multicenter study of the incidence and severity of residual neuromuscular blockade. Anesth Analg. 2015;121:366-372.

Canadian multicentre incidence estimate for residual block; needed only if the day quotes a non-US incidence figure alongside RECITE-US. Cited repeatedly but the primary record was not reached.

Check yourself

Four items. Every option carries an explanation. Progress is not saved.

Progress is not saved. Answers live on this page only and are gone when you leave it. There are no accounts and nothing is recorded.

Item 1 of 4 · pacu-d01-q1

In RECITE-US (Saager 2019), patients were judged ready for extubation by routine clinical judgement and qualitative peripheral nerve stimulation. What proportion had a train-of-four ratio below 0.9 at extubation?

Item 2 of 4 · pacu-d01-q2

In Murphy 2008, patients who developed a critical respiratory event in the first 15 minutes of PACU stay were matched to controls. What was the mean train-of-four ratio in cases versus controls?

Item 3 of 4 · pacu-d01-q3

The 2023 ASA guideline recommends sugammadex for deep, moderate and shallow rocuronium- or vecuronium-induced block. From what depth of block does it describe neostigmine as a reasonable alternative?

Item 4 of 4 · pacu-d01-q4

POPULAR (Kirmeier 2019) found that use of neuromuscular blocking agents was associated with postoperative pulmonary complications, adjusted OR 1.86, and that neither reversal agents nor neuromuscular monitoring reduced that risk in the cohort. How should this day treat that finding?